Core C - FACS and Epigenetics Technology Core

核心C - FACS和表观遗传学技术核心

• 批准号: 8565741
• 负责人: YI ZHOU
• 金额: $ 31.39万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-09-05 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8565741
• 关键词: Biological Models; Blood; Blood Cells; Cell Count; Cell Separation; Cell surface; Cells; Chromatin Structure; Development; Disease; Disease model; Epigenetic Process; Fluorescence; Gene Expression; Hematopoiesis; Hematopoietic; Mammalian Cell; Molecular; Population; Services; Sorting - Cell Movement; Technology; Transgenic Organisms; Zebrafish; chromatin immunoprecipitation; human disease; innovation; member; next generation; novel therapeutic intervention; technology development

and zebrafish model systems developed in the Center. These technologies, fluorescence activated ceil sorting (FACS) and epigenetic analysis on small numbers of cells, will provide an unprecedented view of hematopoiesis. The recent development of technologies such as chromatin immunoprecipitation and next generation sequencing (ChlP-seq) promises to dramatically enhance our understanding of gene expression in hematopoietic cells. CORE C will provide Center members with ready access to the latest, most advanced cell sorting capabilities, and will further develop, apply, and make widely available the most innovative approaches to epigenetic analyses on limiting numbers of primary cells. The efforts of CORE C will significantly lower the barrier to application of these technologies. Significance: A detailed understanding of blood cell development during normal hematopoiesis and various disease states has direct relevance to human disease and will aid in the development of new therapeutic approaches.

以及中心开发的斑马鱼模型系统。这些技术，荧光激活天花板分选